You are here

Article info

Article menu
Download PDFPDF
Clinical science
Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes

Authors

  • Ester Carreño Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK PubMed articlesGoogle scholar articles
  • Tanya Moutray Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK PubMed articlesGoogle scholar articles
  • Konstantinos Fotis Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK PubMed articlesGoogle scholar articles
  • Richard W J Lee Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK Faculty of Medicine and Dentistry, School of Clinical Sciences, University of Bristol, Bristol, UK National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK PubMed articlesGoogle scholar articles
  • Andrew D Dick Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK Faculty of Medicine and Dentistry, School of Clinical Sciences, University of Bristol, Bristol, UK National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK PubMed articlesGoogle scholar articles
  • Adam H Ross Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK PubMed articlesGoogle scholar articles
  • Clare Bailey Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ester Carreño, Bristol Eye Hospital, Lower Maudlin Street, Bristol BS1 2LX, UK; Ester.Carreno-Salas{at}UHBristol.nhs.uk
View Full Text

Citation

Carreño E, Moutray T, Fotis K, et al
Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes
British Journal of Ophthalmology 2016;100:1221-1226.

Publication history

  • Received September 7, 2015
  • Revised November 3, 2015
  • Accepted November 6, 2015
  • First published December 16, 2015.
Online issue publication 
August 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/